Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial

Watchlist | Portfolio | Dashboard

Faster, Cleaner, Better.

Opiant Pharmaceuticals Inc (OPNT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Cash Flow for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	03-2017	01-2017	10-2016	07-2016	04-2016
Cash Flows From Operating Activities
Net Income	-2,797	10,049	-601	N/A	-6,724
Depreciation Amortization	2	3	1	N/A	1
Accounts receivable	N/A	313	-387	N/A	N/A
Accounts payable and accrued liabilities	559	616	502	N/A	-109
Other Working Capital	547	948	123	N/A	-3,944
Other Operating Activity	120	-318	66	0	11,508
Operating Cash Flow	$-1,569	$11,609	$-296	$N/A	$732

Cash Flows From Investing Activities
PPE Investments	N/A	N/A	N/A	N/A	-7
Investing Cash Flow	$N/A	$N/A	$N/A	$N/A	$-7

Cash Flows From Financing Activities
Change In Short Term Borrowing	N/A	N/A	N/A	N/A	151
Other Financing Activity	0	-165	0	0	1,052
Financing Cash Flow	$N/A	$-165	$N/A	$N/A	$1,204

Beginning Cash Position	13,200	1,481	1,481	N/A	434
End Cash Position	11,631	12,926	1,185	N/A	2,364
Net Cash Flow	$-1,569	$11,444	$-296	$N/A	$1,929

Free Cash Flow
Operating Cash Flow	-1,569	11,609	-296	N/A	732
Capital Expenditure	N/A	N/A	N/A	N/A	-7
Free Cash Flow	-1,569	11,609	-296	0	726